Which therapeutic intervention has helped avoid renal failure in patients with Systemic Sclerosis?
The use of ACE inhibitors has dramatically changed the outcome of renal involvement in SSc. Captopril and enalapril are the most studied ACE inhibitors in scleroderma, but probably any of the ACE inhibitors are effective. Angiotensin II receptor antagonists have not been proven effective in treating SRC.
